Huded CP, Chhatriwalla AK, Shah MA, Vemulapalli S, Kosinski A, Cohen DJ. This retrospective cohort study reports that in patients with secondary MR and preserved LVEF, M-TEER was associated with a ...
Bhatia HS, Wandel S, Willeit P, et al. A participant-level meta-analysis of 27,658 participants enrolled in six placebo-controlled statin trials was performed to assess the association of LDL-C and Lp ...
Findings from this retrospective, propensity-matched analysis compared 1-year clinical outcomes for CABG + SVR vs. TAVR + PCI among patients with severe AS and CAD. Patients undergoing TAVR + PCI were ...
In this week’s View, Dr. Eagle looks at contemporary outcomes and trends for the transseptal mitral valve-in-valve procedure using balloon-expandable transcatheter valves. He then explores complete vs ...
The GMRx2 trial showed that a single-pill combination with three antihypertensive agents improves BP control compared with dual combinations of BP medications. Patients with hypertension were ...
The following are key points to remember from a state-of-the-art review about artificial intelligence (AI) in cardiovascular (CV) clinical trials: ...
The Centers for Medicare and Medicaid Services (CMS) released the 2025 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgery Center (ASC) final rule on Nov. 1. The rule will ...
The ACC is seeking its next editor in chief for JACC: Basic to Translational Science (JACC: BTS), an exciting leadership opportunity for a visionary and dynamic thinker eager to shape the future of ...
Bloom JE, Vogrin S, Reid CM, et al. This study was conducted using the Australian and New Zealand Society of Cardiac and Thoracic Surgeons and Melbourne Interventional Group prospective registries.
Revolutionizing the Delivery of Care in CV Disease and T2DM: The Pilot Cardiometabolic Clinic Initiative (UNITE), is a global initiative aimed at improving outcomes of cardiovascular disease risk in ...
Medical therapy is critical in preventing the worst complications of peripheral artery disease (PAD), among them heart attack, stroke, bleeding risk, and leg disease, which could lead to acute limb ...
Beta-blockers have traditionally been considered a cornerstone of therapy after acute myocardial infarction (AMI) regardless of left ventricular ejection fraction (LVEF). Beta-blocker use did not ...